Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001736730-25-000027
Filing Date
2025-04-30
Accepted
2025-04-30 07:00:52
Documents
16
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A camp-20250428.htm   iXBRL DEF 14A 415506
3 camp-20250428_g1.jpg GRAPHIC 26799
4 camp-20250428_g2.jpg GRAPHIC 3827
5 camp-20250428_g3.jpg GRAPHIC 494601
6 camp-20250428_g4.jpg GRAPHIC 238136
  Complete submission text file 0001736730-25-000027.txt   2476571

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT camp-20250428.xsd EX-101.SCH 914
18 EXTRACTED XBRL INSTANCE DOCUMENT camp-20250428_htm.xml XML 4786
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42365 | Film No.: 25890875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)